cached image

Richard B. Mailman - Publications

Affiliations: 
University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
dopamine neuropharmacology
Website:
http://www.med.unc.edu/psych/directories/mailman.htm

213 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Lewis MM, Flynn MR, Lee EY, Buren SV, Buren EV, Du G, Fry RC, Herring AH, Kong L, Mailman RB, Huang X. Longitudinal T1 relaxation rate (R1) captures changes in short-term Mn exposure in welders. Neurotoxicology. PMID 27567731 DOI: 10.1016/j.neuro.2016.08.012  0.68
2016 Arnsten AF, Girgis RR, Gray DL, Mailman RB. Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia. Biological Psychiatry. PMID 26946382 DOI: 10.1016/j.biopsych.2015.12.028  0.68
2015 Du G, Liu T, Lewis MM, Kong L, Wang Y, Connor J, Mailman RB, Huang X. Quantitative susceptibility mapping of the midbrain in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26362242 DOI: 10.1002/mds.26417  0.68
2015 Lee EY, Flynn MR, Du G, Lewis MM, Fry R, Herring AH, Van Buren E, Van Buren S, Smeester L, Kong L, Yang Q, Mailman RB, Huang X. T1 Relaxation Rate (R1) Indicates Nonlinear Mn Accumulation in Brain Tissue of Welders With Low-Level Exposure. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 25953701 DOI: 10.1093/toxsci/kfv088  0.68
2015 Huang X, Alonso A, Guo X, Umbach DM, Lichtenstein ML, Ballantyne CM, Mailman RB, Mosley TH, Chen H. Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 552-9. PMID 25639598 DOI: 10.1002/mds.26152  0.68
2015 Rosell DR, Zaluda LC, McClure MM, Perez-Rodriguez MM, Strike KS, Barch DM, Harvey PD, Girgis RR, Hazlett EA, Mailman RB, Abi-Dargham A, Lieberman JA, Siever LJ. Effects of the D1 dopamine receptor agonist dihydrexidine (DAR-0100A) on working memory in schizotypal personality disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 446-53. PMID 25074637 DOI: 10.1038/npp.2014.192  0.68
2014 Zhang X, Li B, Li W, Ma L, Zheng D, Li L, Yang W, Chu M, Chen W, Mailman RB, Zhu J, Fan G, Archer TK, Wang Y. Transcriptional repression by the BRG1-SWI/SNF complex affects the pluripotency of human embryonic stem cells. Stem Cell Reports. 3: 460-74. PMID 25241744 DOI: 10.1016/j.stemcr.2014.07.004  0.68
2014 Chu M, Wang L, Wang H, Shen T, Yang Y, Sun Y, Tang N, Ni T, Zhu J, Mailman RB, Wang Y. A novel role of CDX1 in embryonic epicardial development. Plos One. 9: e103271. PMID 25068460 DOI: 10.1371/journal.pone.0103271  0.68
2014 Lee SM, Yang Y, Mailman RB. Dopamine D1 receptor signaling: does GαQ-phospholipase C actually play a role? The Journal of Pharmacology and Experimental Therapeutics. 351: 9-17. PMID 25052835 DOI: 10.1124/jpet.114.214411  0.68
2014 Jones BC, Huang X, Mailman RB, Lu L, Williams RW. Response. Journal of Biochemical and Molecular Toxicology. 28: 291. PMID 25044316 DOI: 10.1002/jbt.21591_2  0.68
2014 Lee SM, Kant A, Blake D, Murthy V, Boyd K, Wyrick SJ, Mailman RB. SKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase C. Neuropharmacology. 86: 145-54. PMID 24929112 DOI: 10.1016/j.neuropharm.2014.05.042  0.68
2014 Jones BC, Huang X, Mailman RB, Lu L, Williams RW. The perplexing paradox of paraquat: the case for host-based susceptibility and postulated neurodegenerative effects. Journal of Biochemical and Molecular Toxicology. 28: 191-7. PMID 24599642 DOI: 10.1002/jbt.21552  0.68
2014 Du G, Lewis MM, Sterling NW, Kong L, Chen H, Mailman RB, Huang X. Microstructural changes in the substantia nigra of asymptomatic agricultural workers. Neurotoxicology and Teratology. 41: 60-4. PMID 24334261 DOI: 10.1016/j.ntt.2013.12.001  0.68
2013 Lewis MM, Du G, Kidacki M, Patel N, Shaffer ML, Mailman RB, Huang X. Higher iron in the red nucleus marks Parkinson's dyskinesia. Neurobiology of Aging. 34: 1497-503. PMID 23177595 DOI: 10.1016/j.neurobiolaging.2012.10.025  0.68
2012 Boyd KN, Mailman RB. Dopamine receptor signaling and current and future antipsychotic drugs. Handbook of Experimental Pharmacology. 53-86. PMID 23129328 DOI: 10.1007/978-3-642-25761-2_3  0.68
2012 Du G, Lewis MM, Shaffer ML, Chen H, Yang QX, Mailman RB, Huang X. Serum cholesterol and nigrostriatal R2* values in Parkinson's disease. Plos One. 7: e35397. PMID 22530017 DOI: 10.1371/journal.pone.0035397  0.68
2012 Fowler JC, Bhattacharya S, Urban JD, Vaidehi N, Mailman RB. Receptor conformations involved in dopamine D(2L) receptor functional selectivity induced by selected transmembrane-5 serine mutations. Molecular Pharmacology. 81: 820-31. PMID 22416052 DOI: 10.1124/mol.111.075457  0.68
2012 Boyd KN, Mailman RB. D1/D5 Dopamine Agonists as Pharmacotherapy for Schizophrenia Targets and Emerging Therapies For Schizophrenia. 51-84. DOI: 10.1002/9781118309421.ch3  0.68
2011 Huang X, Auinger P, Eberly S, Oakes D, Schwarzschild M, Ascherio A, Mailman R, Chen H. Serum cholesterol and the progression of parkinson's disease: Results from DATATOP Plos One. 6. PMID 21853051 DOI: 10.1371/journal.pone.0022854  0.68
2011 Gao J, Huang X, Park Y, Liu R, Hollenbeck A, Schatzkin A, Mailman RB, Chen H. Apolipoprotein E genotypes and the risk of Parkinson disease. Neurobiology of Aging. 32: 2106.e1-6. PMID 21741729 DOI: 10.1016/j.neurobiolaging.2011.05.016  0.68
2011 Lewis MM, Du G, Sen S, Kawaguchi A, Truong Y, Lee S, Mailman RB, Huang X. Differential involvement of striato- and cerebello-thalamo-cortical pathways in tremor- and akinetic/rigid-predominant Parkinson's disease. Neuroscience. 177: 230-9. PMID 21211551 DOI: 10.1016/j.neuroscience.2010.12.060  0.68
2010 Chen H, Huang X, Guo X, Mailman RB, Park Y, Kamel F, Umbach DM, Xu Q, Hollenbeck A, Schatzkin A, Blair A. Smoking duration, intensity, and risk of Parkinson disease. Neurology. 74: 878-84. PMID 20220126 DOI: 10.1212/WNL.0b013e3181d55f38  0.68
2010 Huang X, Chen H, Petrovitch H, Mailman R, Ross W. Reply: Plasma cholesterol and Parkinson's disease: Is the puzzle only apparent? Movement Disorders. 25: 137. PMID 20077471 DOI: 10.1002/mds.22793  0.68
2010 Mailman RB, Murthy V. Ligand functional selectivity advances our understanding of drug mechanisms and drug discovery. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 345-6. PMID 20010712 DOI: 10.1038/npp.2009.117  0.68
2010 Mailman RB, Murthy V. Third generation antipsychotic drugs: partial agonism or receptor functional selectivity? Current Pharmaceutical Design. 16: 488-501. PMID 19909227 DOI: 10.2174/138161210790361461  0.68
2009 Lewis MM, Smith AB, Styner M, Gu H, Poole R, Zhu H, Li Y, Barbero X, Gouttard S, McKeown MJ, Mailman RB, Huang X. Asymmetrical lateral ventricular enlargement in Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 16: 475-81. PMID 19187264 DOI: 10.1111/j.1468-1331.2008.02430.x  0.68
2009 Brown JT, Kant A, Mailman RB. Rapid, semi-automated, and inexpensive radioimmunoassay of cAMP: application in GPCR-mediated adenylate cyclase assays. Journal of Neuroscience Methods. 177: 261-6. PMID 19007813 DOI: 10.1016/j.jneumeth.2008.10.016  0.68
2008 Huang X, Abbott RD, Petrovitch H, Mailman RB, Ross GW. Low LDL cholesterol and increased risk of Parkinson's disease: prospective results from Honolulu-Asia Aging Study. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1013-8. PMID 18381649 DOI: 10.1002/mds.22013  0.68
2007 Mailman RB, Huang X. Dopamine receptor pharmacology. Handbook of Clinical Neurology. 83: 77-105. PMID 18808911 DOI: 10.1016/S0072-9752(07)83004-1  0.68
2007 Mailman RB. GPCR functional selectivity has therapeutic impact. Trends in Pharmacological Sciences. 28: 390-6. PMID 17629962 DOI: 10.1016/j.tips.2007.06.002  0.68
2007 Mu Q, Johnson K, Morgan PS, Grenesko EL, Molnar CE, Anderson B, Nahas Z, Kozel FA, Kose S, Knable M, Fernandes P, Nichols DE, Mailman RB, George MS. A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia. Schizophrenia Research. 94: 332-41. PMID 17596915 DOI: 10.1016/j.schres.2007.03.033  0.68
2007 Lewis MM, Slagle CG, Smith AB, Truong Y, Bai P, McKeown MJ, Mailman RB, Belger A, Huang X. Task specific influences of Parkinson's disease on the striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries. Neuroscience. 147: 224-35. PMID 17499933 DOI: 10.1016/j.neuroscience.2007.04.006  0.68
2007 George MS, Molnar CE, Grenesko EL, Anderson B, Mu Q, Johnson K, Nahas Z, Knable M, Fernandes P, Juncos J, Huang X, Nichols DE, Mailman RB. A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia. Schizophrenia Research. 93: 42-50. PMID 17467956 DOI: 10.1016/j.schres.2007.03.011  0.68
2007 Huang X, Chen H, Miller WC, Mailman RB, Woodard JL, Chen PC, Xiang D, Murrow RW, Wang YZ, Poole C. Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 377-81. PMID 17177184 DOI: 10.1002/mds.21290  0.68
2007 Ryman-Rasmussen JP, Griffith A, Oloff S, Vaidehi N, Brown JT, Goddard WA, Mailman RB. Functional selectivity of dopamine D1 receptor agonists in regulating the fate of internalized receptors. Neuropharmacology. 52: 562-75. PMID 17067639 DOI: 10.1016/j.neuropharm.2006.08.028  0.68
2007 Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka B, Weinstein H, Javitch JA, Roth BL, Christopoulos A, Sexton PM, Miller KJ, Spedding M, Mailman RB. Functional selectivity and classical concepts of quantitative pharmacology. The Journal of Pharmacology and Experimental Therapeutics. 320: 1-13. PMID 16803859 DOI: 10.1124/jpet.106.104463  0.68
2007 Urban JD, Vargas GA, von Zastrow M, Mailman RB. Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 67-77. PMID 16554739 DOI: 10.1038/sj.npp.1301071  0.68
2007 Mailman RB. Toxicant-Receptor Interactions: Fundamental Principles Molecular and Biochemical Toxicology, Fourth Edition. 359-388. DOI: 10.1002/9780470285251.ch19  0.68
2006 Leonard SK, Ferry-Leeper P, Mailman RB. Low affinity binding of the classical D1 antagonist SCH23390 in rodent brain: potential interaction with A2A and D2-like receptors. Brain Research. 1117: 25-37. PMID 16962565 DOI: 10.1016/j.brainres.2006.08.024  0.68
2006 Lewis MM, Huang X, Nichols DE, Mailman RB. D1 and functionally selective dopamine agonists as neuroprotective agents in Parkinson's disease. Cns & Neurological Disorders Drug Targets. 5: 345-53. PMID 16787233 DOI: 10.2174/187152706777452245  0.68
2005 Oloff S, Mailman RB, Tropsha A. Application of validated QSAR models of D1 dopaminergic antagonists for database mining. Journal of Medicinal Chemistry. 48: 7322-32. PMID 16279792 DOI: 10.1021/jm049116m  0.68
2005 Padilla S, Marshall RS, Hunter DL, Oxendine S, Moser VC, Southerland SB, Mailman RB. Neurochemical effects of chronic dietary and repeated high-level acute exposure to chlorpyrifos in rats. Toxicological Sciences : An Official Journal of the Society of Toxicology. 88: 161-71. PMID 16081522 DOI: 10.1093/toxsci/kfi274  0.68
2005 Ryman-Rasmussen JP, Nichols DE, Mailman RB. Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists. Molecular Pharmacology. 68: 1039-48. PMID 15985612 DOI: 10.1124/mol.105.012153  0.68
2004 Gay EA, Urban JD, Nichols DE, Oxford GS, Mailman RB. Functional selectivity of D2 receptor ligands in a Chinese hamster ovary hD2L cell line: evidence for induction of ligand-specific receptor states. Molecular Pharmacology. 66: 97-105. PMID 15213300 DOI: 10.1124/mol.66.1.97  0.68
2004 Grubbs RA, Lewis MM, Owens-Vance C, Gay EA, Jassen AK, Mailman RB, Nichols DE. 8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms. Bioorganic & Medicinal Chemistry. 12: 1403-12. PMID 15018913 DOI: 10.1016/j.bmc.2004.01.008  0.68
2004 Sit SY, Xie K, Jacutin-Porte S, Boy KM, Seanz J, Taber MT, Gulwadi AG, Korpinen CD, Burris KD, Molski TF, Ryan E, Xu C, Verdoorn T, Johnson G, Nichols DE, ... Mailman RB, et al. Synthesis and SAR exploration of dinapsoline analogues. Bioorganic & Medicinal Chemistry. 12: 715-34. PMID 14759732 DOI: 10.1016/j.bmc.2003.11.015  0.68
2004 Mailman RB, Gay EA. Novel mechanisms of drug action: Functional selectivity at D2 dopamine receptors (a lesson for drug discovery) Medicinal Chemistry Research. 13: 115-126. DOI: 10.1007/s00044-004-0017-7  0.68
2003 Leonard SK, Anderson CM, Lachowicz JE, Schulz DW, Kilts CD, Mailman RB. Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase. Synapse (New York, N.Y.). 50: 320-33. PMID 14556237 DOI: 10.1002/syn.10272  0.68
2003 Shapiro DA, Renock S, Arrington E, Chiodo LA, Liu LX, Sibley DR, Roth BL, Mailman R. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1400-11. PMID 12784105 DOI: 10.1038/sj.npp.1300203  0.68
2003 Qandil AM, Lewis MM, Jassen A, Leonard SK, Mailman RB, Nichols DE. Synthesis and pharmacological evaluation of substituted naphth[1,2,3-de]isoquinolines (dinapsoline analogues) as D1 and D2 dopamine receptor ligands. Bioorganic & Medicinal Chemistry. 11: 1451-64. PMID 12628671 DOI: 10.1016/S0968-0896(02)00561-8  0.68
2003 Leonard SK, Petitto JM, Anderson CM, Mooney DH, Lachowicz JE, Schulz DW, Kilts CD, Mailman RB. D1 dopamine receptors in the amygdala exhibit unique properties Annals of the New York Academy of Sciences. 985: 536-539.  0.68
2002 Andersson C, Hamer RM, Lawler CP, Mailman RB, Lieberman JA. Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 143-51. PMID 12093588 DOI: 10.1016/S0893-133X(02)00287-7  0.68
2002 Kilts JD, Connery HS, Arrington EG, Lewis MM, Lawler CP, Oxford GS, O'Malley KL, Todd RD, Blake BL, Nichols DE, Mailman RB. Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs. The Journal of Pharmacology and Experimental Therapeutics. 301: 1179-89. PMID 12023553 DOI: 10.1124/jpet.301.3.1179  0.68
2002 Mottola DM, Kilts JD, Lewis MM, Connery HS, Walker QD, Jones SR, Booth RG, Hyslop DK, Piercey M, Wightman RM, Lawler CP, Nichols DE, Mailman RB. Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase. The Journal of Pharmacology and Experimental Therapeutics. 301: 1166-78. PMID 12023552 DOI: 10.1124/jpet.301.3.1166  0.68
2001 Mailman R, Huang X, Nichols DE. Parkinson's disease and D1 dopamine receptors. Current Opinion in Investigational Drugs (London, England : 2000). 2: 1582-91. PMID 11763161  0.68
2001 Huang X, Lawler CP, Lewis MM, Nichols DE, Mailman RB. D1 dopamine receptors. International Review of Neurobiology. 48: 65-139. PMID 11526741  0.68
2001 Miyamoto S, Mailman RB, Lieberman JA, Duncan GE. Blunted brain metabolic response to ketamine in mice lacking D(1A) dopamine receptors. Brain Research. 894: 167-80. PMID 11251190 DOI: 10.1016/S0006-8993(01)01991-6  0.68
2001 Montague DM, Striplin CD, Overcash JS, Drago J, Lawler CP, Mailman RB. Quantification of D1B(D5) receptors in dopamine D1A receptor-deficient mice. Synapse (New York, N.Y.). 39: 319-22. PMID 11169782 DOI: 10.1002/1098-2396(20010315)39:4<319::AID-SYN1015>3.0.CO;2-1  0.68
2001 Gulwadi AG, Korpinen CD, Mailman RB, Nichols DE, Sit SY, Taber MT. Dinapsoline: characterization of a D1 dopamine receptor agonist in a rat model of Parkinson's disease. The Journal of Pharmacology and Experimental Therapeutics. 296: 338-44. PMID 11160615  0.68
2000 Miyamoto S, Duncan GE, Mailman RB, Lieberman JA. Developing novel antipsychotic drugs: Strategies and goals Current Opinion in Central and Peripheral Nervous System Investigational Drugs. 2: 25-39.  0.68
1999 Montague DM, Lawler CP, Mailman RB, Gilmore JH. Developmental regulation of the dopamine D1 receptor in human caudate and putamen. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 21: 641-9. PMID 10516960 DOI: 10.1016/S0893-133X(99)00062-7  0.68
1999 Hoffman B, Cho SJ, Zheng W, Wyrick S, Nichols DE, Mailman RB, Tropsha A. Quantitative structure-activity relationship modeling of dopamine D(1) antagonists using comparative molecular field analysis, genetic algorithms-partial least-squares, and K nearest neighbor methods. Journal of Medicinal Chemistry. 42: 3217-26. PMID 10464009 DOI: 10.1021/jm980415j  0.68
1999 Lawler CP, Prioleau C, Lewis MM, Mak C, Jiang D, Schetz JA, Gonzalez AM, Sibley DR, Mailman RB. Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 20: 612-27. PMID 10327430 DOI: 10.1016/S0893-133X(98)00099-2  0.68
1999 Doll MK, Nichols DE, Kilts JD, Prioleau C, Lawler CP, Lewis MM, Mailman RB. Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quinelorane. Journal of Medicinal Chemistry. 42: 935-40. PMID 10072690 DOI: 10.1021/jm9804533  0.68
1998 Lieberman JA, Mailman RB, Duncan G, Sikich L, Chakos M, Nichols DE, Kraus JE. Serotonergic basis of antipsychotic drug effects in schizophrenia. Biological Psychiatry. 44: 1099-117. PMID 9836014 DOI: 10.1016/S0006-3223(98)00187-5  0.68
1998 Duncan GE, Leipzig JN, Mailman RB, Lieberman JA. Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation. Brain Research. 812: 65-75. PMID 9813244 DOI: 10.1016/S0006-8993(98)00926-3  0.68
1998 Mailman RB, Nichols DE. Dopamine D1 receptor agonists as antiparkinson drugs. Trends in Pharmacological Sciences. 19: 255-6. PMID 9703756 DOI: 10.1016/S0165-6147(98)01219-X  0.68
1998 Smith DR, Striplin CD, Geller AM, Mailman RB, Drago J, Lawler CP, Gallagher M. Behavioural assessment of mice lacking D1A dopamine receptors. Neuroscience. 86: 135-46. PMID 9692749 DOI: 10.1016/S0306-4522(97)00608-8  0.68
1998 Lewis MM, Watts VJ, Lawler CP, Nichols DE, Mailman RB. Homologous desensitization of the D1A dopamine receptor: efficacy in causing desensitization dissociates from both receptor occupancy and functional potency. The Journal of Pharmacology and Experimental Therapeutics. 286: 345-53. PMID 9655879  0.68
1998 Monte AP, Marona-Lewicka D, Lewis MM, Mailman RB, Wainscott DB, Nelson DL, Nichols DE. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity. Journal of Medicinal Chemistry. 41: 2134-45. PMID 9622555 DOI: 10.1021/jm980076u  0.68
1998 Anderson C, Chakos M, Mailman R, Lieberman J. Emerging roles for novel antipsychotic medications in the treatment of schizophrenia Psychiatric Clinics of North America. 21: 151-179. PMID 9551495 DOI: 10.1016/S0193-953X(05)70365-8  0.68
1998 Lieberman JA, Mailman R. Decline of dopamine: Effects of age and acute neuroleptic challenge American Journal of Psychiatry. 155: 319-323. PMID 9501739  0.68
1998 Bunin MA, Prioleau C, Mailman RB, Wightman RM. Release and uptake rates of 5-hydroxytryptamine in the dorsal raphe and substantia nigra reticulata of the rat brain. Journal of Neurochemistry. 70: 1077-87. PMID 9489728  0.68
1997 Negash K, Nichols DE, Watts VJ, Mailman RB. Further definition of the D1 dopamine receptor pharmacophore: synthesis of trans-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphth[2,1-b]azepines as rigid analogues of beta-phenyldopamine. Journal of Medicinal Chemistry. 40: 2140-7. PMID 9216832 DOI: 10.1021/jm970157a  0.68
1997 Smith HP, Nichols DE, Mailman RB, Lawler CP. Locomotor inhibition, yawning and vacuous chewing induced by a novel dopamine D2 post-synaptic receptor agonist. European Journal of Pharmacology. 323: 27-36. PMID 9105873 DOI: 10.1016/S0014-2999(97)00026-5  0.68
1997 Bodfish JW, McCuller WR, Madison JM, Register M, Mailman RB, Lewis MH. Placebo, Double-Blind Evaluation of Long-Term Naltrexone Treatment Effects for Adults with Mental Retardation and Self-Injury Journal of Developmental and Physical Disabilities. 9: 135-152.  0.68
1996 Walker QD, Mailman RB. Triadimefon and triadimenol: effects on monoamine uptake and release. Toxicology and Applied Pharmacology. 139: 227-33. PMID 8806838 DOI: 10.1006/taap.1996.0161  0.68
1996 Mottola DM, Laiter S, Watts VJ, Tropsha A, Wyrick SD, Nichols DE, Mailman RB. Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping. Journal of Medicinal Chemistry. 39: 285-96. PMID 8568818 DOI: 10.1021/jm9502100  0.68
1996 Ghosh D, Snyder SE, Watts VJ, Mailman RB, Nichols DE. 9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore. Journal of Medicinal Chemistry. 39: 549-55. PMID 8558526 DOI: 10.1021/jm950707+  0.68
1995 Lawler CP, Gilmore JH, Watts VJ, Walker QD, Southerland SB, Cook LL, Mathis CA, Mailman RB. Interhemispheric modulation of dopamine receptor interactions in unilateral 6-OHDA rodent model. Synapse (New York, N.Y.). 21: 299-311. PMID 8869160 DOI: 10.1002/syn.890210404  0.68
1995 Watts VJ, Lawler CP, Gonzales AJ, Zhou QY, Civelli O, Nichols DE, Mailman RB. Spare receptors and intrinsic activity: studies with D1 dopamine receptor agonists. Synapse (New York, N.Y.). 21: 177-87. PMID 8584979 DOI: 10.1002/syn.890210211  0.68
1995 Brewster WK, Nichols DE, Watts VJ, Riggs RM, Mottola D, Mailman RB. Evaluation of cis- and trans-9- and 11-hydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridines as structurally rigid, selective D1 dopamine receptor ligands. Journal of Medicinal Chemistry. 38: 318-27. PMID 7830274  0.68
1995 Heidenreich BA, Mailman RB, Nichols DE, Napier TC. Partial and full dopamine D1 agonists produce comparable increases in ventral pallidal neuronal activity: contribution of endogenous dopamine. The Journal of Pharmacology and Experimental Therapeutics. 273: 516-25. PMID 7714807  0.68
1995 Gariépy JL, Gendreau PL, Mailman RB, Tancer M, Lewis MH. Rearing conditions alter social reactivity and D1 dopamine receptors in high- and low-aggressive mice. Pharmacology, Biochemistry, and Behavior. 51: 767-73. PMID 7675857 DOI: 10.1016/0091-3057(95)00028-U  0.68
1995 Blake BL, Rose RL, Mailman RB, Levi PE, Hodgson E. Metabolism of thioridazine by microsomal monooxygenases: relative roles of P450 and flavin-containing monooxygenase. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 25: 377-93. PMID 7645304 DOI: 10.3109/00498259509061859  0.68
1995 Knoerzer TA, Watts VJ, Nichols DE, Mailman RB. Synthesis and biological evaluation of a series of substituted benzo[a]phenanthridines as agonists at D1 and D2 dopamine receptors. Journal of Medicinal Chemistry. 38: 3062-70. PMID 7636869  0.68
1995 Snyder SE, Aviles-Garay FA, Chakraborti R, Nichols DE, Watts VJ, Mailman RB. Synthesis and evaluation of 6,7-dihydroxy-2,3,4,8,9,13b-hexahydro-1H- benzo[6,7]cyclohepta[1,2,3-ef][3]benzazepine, 6,7-dihydroxy- 1,2,3,4,8,12b-hexahydroanthr[10,4a,4-cd]azepine, and 10-(aminomethyl)-9,10- dihydro-1,2-dihydroxyanthracene as conformationally restricted analogs of beta-phenyldopamine. Journal of Medicinal Chemistry. 38: 2395-409. PMID 7608904  0.68
1995 Watts VJ, Lawler CP, Fox DR, Neve KA, Nichols DE, Mailman RB. LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors. Psychopharmacology. 118: 401-9. PMID 7568626 DOI: 10.1007/BF02245940  0.68
1995 Gilmore JH, Watts VJ, Lawler CP, Noll EP, Nichols DE, Mailman RB. "Full" dopamine D1 agonists in human caudate: biochemical properties and therapeutic implications. Neuropharmacology. 34: 481-8. PMID 7566481 DOI: 10.1016/0028-3908(95)00014-W  0.68
1995 Wyrick SD, Booth RG, Myers AM, Owens CE, Bucholtz EC, Hooper PC, Kula NS, Baldessarini RJ, Mailman RB. 1-Phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes and related derivatives as ligands for the neuromodulatory sigma 3 receptor: further structure-activity relationships. Journal of Medicinal Chemistry. 38: 3857-64. PMID 7562917  0.68
1994 Tancer ME, Mailman RB, Stein MB, Mason GA, Carson SW, Golden RN. Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia. Anxiety. 1: 216-23. PMID 9160577  0.68
1994 Martin P, Ohno M, Southerland SB, Mailman RB, Suzuki K. Heterotypic sprouting of serotonergic forebrain fibers in the brindled mottled mutant mouse. Brain Research. Developmental Brain Research. 77: 215-25. PMID 8174230 DOI: 10.1016/0165-3806(94)90198-8  0.68
1994 Hudkins RL, Mailman RB, DeHaven-Hudkins DL. Novel (4-phenylpiperidinyl)- and (4-phenylpiperazinyl)alkyl-spaced esters of 1-phenylcyclopentanecarboxylic acids as potent sigma-selective compounds. Journal of Medicinal Chemistry. 37: 1964-70. PMID 8027978  0.68
1994 Minor DL, Wyrick SD, Charifson PS, Watts VJ, Nichols DE, Mailman RB. Synthesis and molecular modeling of 1-phenyl-1,2,3,4-tetrahydroisoquinolines and related 5,6,8,9-tetrahydro-13bH-dibenzo[a,h]quinolizines as D1 dopamine antagonists. Journal of Medicinal Chemistry. 37: 4317-28. PMID 7996543  0.68
1994 Knoerzer TA, Nichols DE, Brewster WK, Watts VJ, Mottola D, Mailman RB. Dopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist. Journal of Medicinal Chemistry. 37: 2453-60. PMID 7914538  0.68
1994 Lewis MH, Gariépy JL, Gendreau P, Nichols DE, Mailman RB. Social reactivity and D1 dopamine receptors: studies in mice selectively bred for high and low levels of aggression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 10: 115-22. PMID 7912934 DOI: 10.1038/npp.1994.13  0.68
1994 Hudkins RL, Mailman RB, DeHaven-Hudkins DL. RLH-033, a novel, potent and selective ligand for the sigma 1 recognition site. European Journal of Pharmacology. 271: 235-6. PMID 7698207 DOI: 10.1016/0014-2999(94)90286-0  0.68
1994 Wyrick SD, Myers AM, Booth RG, Kula NS, Baldessarini RJ, Mailman RB. Synthesis of [N-C3H3]-trans-(1R,3S)-(-)-1-phenyl-3-N,N-dimethylamino-1,2,3,4-tetr ahydronaphthalene (H2-PAT) Journal of Labelled Compounds and Radiopharmaceuticals. 34: 131-134. DOI: 10.1002/jlcr.2580340205  0.68
1993 Gilmore JH, Lawler CP, Eaton AM, Mailman RB. Postmortem stability of dopamine D1 receptor mRNA and D1 receptors. Brain Research. Molecular Brain Research. 18: 290-6. PMID 8326824 DOI: 10.1016/0169-328X(93)90092-4  0.68
1993 Lawler CP, Gilmore JH, Mooney DH, Mayleben MA, Atashi JR, Mileson BE, Wyrick SD, Mailman RB. A rapid and efficient method for the radiosynthesis and purification of [125I]SCH23982. Journal of Neuroscience Methods. 49: 141-53. PMID 8271827 DOI: 10.1016/0165-0270(93)90118-B  0.68
1993 Booth RG, Wyrick SD, Baldessarini RJ, Kula NS, Myers AM, Mailman RB. New sigma-like receptor recognized by novel phenylaminotetralins: ligand binding and functional studies. Molecular Pharmacology. 44: 1232-9. PMID 8264560  0.68
1993 Watts VJ, Lawler CP, Knoerzer T, Mayleben MA, Neve KA, Nichols DE, Mailman RB. Hexahydrobenzo[a]phenanthridines: novel dopamine D3 receptor ligands. European Journal of Pharmacology. 239: 271-3. PMID 8223910 DOI: 10.1016/0014-2999(93)91012-C  0.68
1993 Wyrick SD, Booth RG, Myers AM, Owens CE, Kula NS, Baldessarini RJ, McPhail AT, Mailman RB. Synthesis and pharmacological evaluation of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for a novel receptor with sigma-like neuromodulatory activity. Journal of Medicinal Chemistry. 36: 2542-51. PMID 8102651  0.68
1993 Watts VJ, Lawler CP, Gilmore JH, Southerland SB, Nichols DE, Mailman RB. Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents. European Journal of Pharmacology. 242: 165-72. PMID 7902811 DOI: 10.1016/0014-2999(93)90076-T  0.68
1992 Mottola DM, Brewster WK, Cook LL, Nichols DE, Mailman RB. Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist. The Journal of Pharmacology and Experimental Therapeutics. 262: 383-93. PMID 1352553  0.68
1991 Bishop JE, Mathis CA, Gerdes JM, Whitney JM, Eaton AM, Mailman RB. Synthesis and in vitro evaluation of 2,3-dimethoxy-5-(fluoroalkyl)-substituted benzamides: high-affinity ligands for CNS dopamine D2 receptors. Journal of Medicinal Chemistry. 34: 1612-24. PMID 1827843  0.68
1991 Martin PM, Irino M, Suzuki K, Lewis MH, Mailman RB. The female brindled mouse as a model of Menkes' disease: the relationship of fur pattern to behavioral and neurochemical abnormalities. Developmental Neuroscience. 13: 121-9. PMID 1752214 DOI: 10.1159/000112149  0.68
1991 Lovenberg TW, Roth RH, Nichols DE, Mailman RB. D1 dopamine receptors of NS20Y neuroblastoma cells are functionally similar to rat striatal D1 receptors. Journal of Neurochemistry. 57: 1563-9. PMID 1717649  0.68
1991 Mileson BE, Lewis MH, Mailman RB. Dopamine receptor 'supersensitivity' occurring without receptor up-regulation. Brain Research. 561: 1-10. PMID 1686741 DOI: 10.1016/0006-8993(91)90742-E  0.68
1991 Darney KJ, Lewis MH, Brewster WK, Nichols DE, Mailman RB. Behavioral effects in the rat of dihydrexidine, a high-potency, full-efficacy D1 dopamine receptor agonist. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 5: 187-95. PMID 1684499  0.68
1991 Satoh J, Irino M, Martin PM, Mailman RB, Suzuki K. Neurochemical and immunocytochemical studies of catecholamine system in the brindled mouse. Journal of Neuropathology and Experimental Neurology. 50: 793-808. PMID 1684202  0.68
1991 Elsworth JD, Lawrence MS, Roth RH, Taylor JR, Mailman RB, Nichols DE, Lewis MH, Redmond DE. D1 and D2 dopamine receptors independently regulate spontaneous blink rate in the vervet monkey. The Journal of Pharmacology and Experimental Therapeutics. 259: 595-600. PMID 1682479  0.68
1991 Lovenberg TW, Nichols DE, Nestler EJ, Roth RH, Mailman RB. Guanine nucleotide binding proteins and the regulation of cyclic AMP synthesis in NS20Y neuroblastoma cells: role of D1 dopamine and muscarinic receptors. Brain Research. 556: 101-7. PMID 1682005 DOI: 10.1016/0006-8993(91)90552-7  0.68
1991 Taylor JR, Lawrence MS, Redmond DE, Elsworth JD, Roth RH, Nichols DE, Mailman RB. Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys. European Journal of Pharmacology. 199: 389-91. PMID 1680717 DOI: 10.1016/0014-2999(91)90508-N  0.68
1990 Walker QD, Lewis MH, Crofton KM, Mailman RB. Triadimefon, a triazole fungicide, induces stereotyped behavior and alters monoamine metabolism in rats. Toxicology and Applied Pharmacology. 102: 474-85. PMID 2315916 DOI: 10.1016/0041-008X(90)90043-T  0.68
1990 Brewster WK, Nichols DE, Riggs RM, Mottola DM, Lovenberg TW, Lewis MH, Mailman RB. trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist. Journal of Medicinal Chemistry. 33: 1756-64. PMID 1971308  0.68
1990 Lewis MH, Gluck JP, Beauchamp AJ, Keresztury MF, Mailman RB. Long-term effects of early social isolation in Macaca mulatta: changes in dopamine receptor function following apomorphine challenge. Brain Research. 513: 67-73. PMID 1693540 DOI: 10.1016/0006-8993(90)91089-Y  0.68
1989 Jimmerson VR, Shih TM, Mailman RB. Variability in soman toxicity in the rat: correlation with biochemical and behavioral measures. Toxicology. 57: 241-54. PMID 2756526 DOI: 10.1016/0300-483X(89)90114-5  0.68
1989 Jimmerson VR, Shih TM, Maxwell DM, Mailman RB. Cresylbenzodioxaphosphorin oxide pretreatment alters soman-induced toxicity and inhibition of tissue cholinesterase activity of the rat. Toxicology Letters. 48: 93-103. PMID 2749782 DOI: 10.1016/0378-4274(89)90190-2  0.68
1989 Niedzwiecki DM, Cubeddu LX, Mailman RB. Comparative anticholinergic properties of thioridazine, mesoridazine and sulforidazine. The Journal of Pharmacology and Experimental Therapeutics. 250: 126-33. PMID 2746492  0.68
1989 Niedzwiecki DM, Cubeddu LX, Mailman RB. Comparative antidopaminergic properties of thioridazine, mesoridazine and sulforidazine on the corpus striatum. The Journal of Pharmacology and Experimental Therapeutics. 250: 117-25. PMID 2746491  0.68
1989 Herr DW, Mailman RB. Buffer effects on high affinity [3H]-prazosin binding in brain and spinal cord. Pharmacology, Biochemistry, and Behavior. 32: 831-4. PMID 2740434 DOI: 10.1016/0091-3057(89)90043-9  0.68
1989 Jimmerson VR, Shih TM, Maxwell DM, Kaminskis A, Mailman RB. The effect of 2-(o-cresyl)-4H-1:3:2-benzodioxaphosphorin-2-oxide on tissue cholinesterase and carboxylesterase activities of the rat. Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology. 13: 568-75. PMID 2612789 DOI: 10.1093/toxsci/13.3.568  0.68
1989 Lovenberg TW, Brewster WK, Mottola DM, Lee RC, Riggs RM, Nichols DE, Lewis MH, Mailman RB. Dihydrexidine, a novel selective high potency full dopamine D-1 receptor agonist. European Journal of Pharmacology. 166: 111-3. PMID 2572425 DOI: 10.1016/0014-2999(89)90690-0  0.68
1989 Herr DW, Mailman RB, Tilson HA. Blockade of only spinal alpha 1 adrenoceptors is insufficient to attenuate DDT-induced alterations in motor function. Toxicology and Applied Pharmacology. 101: 11-26. PMID 2552613 DOI: 10.1016/0041-008X(89)90207-X  0.68
1989 Charifson PS, Bowen JP, Wyrick SD, Hoffman AJ, Cory M, McPhail AT, Mailman RB. Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligands. Journal of Medicinal Chemistry. 32: 2050-8. PMID 2527994  0.68
1988 Kilts CD, Anderson CM, Ely TD, Mailman RB. The biochemistry and pharmacology of mesoamygdaloid dopamine neurons. Annals of the New York Academy of Sciences. 537: 173-87. PMID 3059923  0.68
1988 Charifson PS, Wyrick SD, Hoffman AJ, Simmons RM, Bowen JP, McDougald DL, Mailman RB. Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligands. Journal of Medicinal Chemistry. 31: 1941-6. PMID 3050089  0.68
1988 DeHaven-Hudkins DL, Schulz DW, Walsh TJ, Mailman RB. Responses of dopaminergic and serotonergic systems to triethyllead intoxication. Neurotoxicology and Teratology. 10: 279-85. PMID 2465482 DOI: 10.1016/0892-0362(88)90029-3  0.68
1987 Konkol RJ, Chapman L, Breese GR, Collier AM, Kilts C, Finley C, Vogel RR, Mailman RB, Bendeich EG. Hemophilus influenzae meningitis in the rat: behavioral, electrophysiological, and biochemical consequences. Annals of Neurology. 21: 353-60. PMID 3579220 DOI: 10.1002/ana.410210407  0.68
1987 Mailman RB. Mechanisms of CNS injury in behavioral dysfunction. Neurotoxicology and Teratology. 9: 417-26. PMID 3325802 DOI: 10.1016/0892-0362(87)90054-7  0.68
1987 Lewis MH, Baumeister AA, Mailman RB. A neurobiological alternative to the perceptual reinforcement hypothesis of stereotyped behavior: a commentary on "Self-stimulatory behavior and perceptual reinforcement". Journal of Applied Behavior Analysis. 20: 253-8. PMID 3312139 DOI: 10.1901/jaba.1987.20-253  0.68
1987 Mailman RB, Lewis MH. Neurotoxicants and central catecholamine systems. Neurotoxicology. 8: 123-39. PMID 3031560  0.68
1987 Crofton KM, Reiter LW, Mailman RB. Pyrethroid insecticides and radioligand displacement from the GABA receptor chloride ionophore complex. Toxicology Letters. 35: 183-90. PMID 3029901 DOI: 10.1016/0378-4274(87)90205-0  0.68
1986 Rollema H, Feenstra MG, Grol CJ, Lewis MH, Staples L, Mailman RB. S(-)DP-5,6-ADTN as an in vivo dopamine receptor ligand: relation between displacement by dopamine agonists and their pharmacological effects. Naunyn-Schmiedeberg's Archives of Pharmacology. 332: 338-45. PMID 3736679 DOI: 10.1007/BF00500084  0.68
1986 Twery MJ, Kirkpatrick B, Lewis MH, Mailman RB, Cooper CW. Antagonistic behavioral effects of calcitonin and amphetamine in the rat. Pharmacology, Biochemistry, and Behavior. 24: 1203-7. PMID 3725826 DOI: 10.1016/0091-3057(86)90171-1  0.68
1986 Twery MJ, Kirkpatrick B, Critcher EC, Lewis MH, Mailman RB, Cooper CW. Motor effects of calcitonin administered intracerebroventricularly in the rat. European Journal of Pharmacology. 121: 189-98. PMID 3699092 DOI: 10.1016/0014-2999(86)90490-5  0.68
1986 Napier TC, Givens BS, Schulz DW, Bunney BS, Breese GR, Mailman RB. SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons. The Journal of Pharmacology and Experimental Therapeutics. 236: 838-45. PMID 3512819  0.68
1986 Mailman RB, Schulz DW, Kilts CD, Lewis MH, Rollema H, Wyrick S. The multiplicity of the D1 dopamine receptor. Advances in Experimental Medicine and Biology. 204: 53-72. PMID 2947430  0.68
1986 Mailman RB, Schulz DW, Kilts CD, Lewis MH, Rollema H, Wyrick S. Multiple forms of the D1 dopamine receptor: its linkage to adenylate cyclase and psychopharmacological effects. Psychopharmacology Bulletin. 22: 593-8. PMID 2879302  0.68
1986 DeHaven DL, Krigman MR, Mailman RB. Temporal changes in dopaminergic and serotonergic function caused by administration of trimethyltin to adult rats. Neurobehavioral Toxicology and Teratology. 8: 475-9. PMID 2431332  0.68
1986 Wyrick SD, Niedzwiecki DM, Mailman RB. Tritium labelled (±)-10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylmercapto) -[3-3H(n)]phenothiazine (thioridazine) Journal of Labelled Compounds and Radiopharmaceuticals. 23: 95-101.  0.68
1986 Wyrick SD, McDougald DL, Mailman RB. Multiple tritium labelling of (+)-7-chloro-8-hydroxy-1-phenyl-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SCH23390) Journal of Labelled Compounds and Radiopharmaceuticals. 23: 685-692.  0.68
1985 Lewis MH, Baumeister AA, McCorkle DL, Mailman RB. A computer-supported method for analyzing behavioral observations: studies with stereotypy. Psychopharmacology. 85: 204-9. PMID 3925484 DOI: 10.1007/BF00428415  0.68
1985 Schulz DW, Staples L, Mailman RB. SCH23390 causes persistent antidopaminergic effects in vivo: evidence for longterm occupation of receptors. Life Sciences. 36: 1941-8. PMID 3887084 DOI: 10.1016/0024-3205(85)90443-6  0.68
1985 Kilts CD, Dew KL, Ely TD, Mailman RB. Quantification of R-(+)-7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-methyl-3- benzazepine in brain and blood by use of reversed-phase high-performance liquid chromatography with electrochemical detection. Journal of Chromatography. 342: 452-7. PMID 2865269 DOI: 10.1016/S0378-4347(00)84543-0  0.68
1985 Schulz DW, Stanford EJ, Wyrick SW, Mailman RB. Binding of [3H]SCH23390 in rat brain: regional distribution and effects of assay conditions and GTP suggest interactions at a D1-like dopamine receptor. Journal of Neurochemistry. 45: 1601-11. PMID 2864398  0.68
1985 Mailman RB, Kilts CD. Analytical considerations for quantitative determination of serotonin and its metabolically related products in biological matrices. Clinical Chemistry. 31: 1849-54. PMID 2414038  0.68
1985 Mailman RB, Widerlov E, Kilts CD, Lewis MH. Tioridazin - ett atypiskt neuroleptikum?: Översikt över farmakodynamiska effekter av tioridazin och dess huvudmetaboliter Nordic Journal of Psychiatry. 39: 395-404. DOI: 10.3109/08039488509101928  0.68
1985 Mailman RB, Widerlov E, Kilts CD, Lewis MH. Thioridazine - an atypical neuroleptic drug? Nordisk Psykiatrisk Tidsskrift. 39: 395-404.  0.68
1985 Wyrick SD, Mailman RB. Tritium labelled (±)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3- benzazepine (SCH23390) Journal of Labelled Compounds and Radiopharmaceuticals. 22: 189-195.  0.68
1984 Schulz DW, Lewis MH, Petitto J, Mailman RB. Ascorbic acid decreases [(3)H]dopamine binding in striatum without inhibiting dopamine-sensitive adenylate cyclase. Neurochemistry International. 6: 117-21. PMID 20488029  0.4
1984 Mailman RB, Pierce JP, Crofton KM, Petitto J, DeHaven DL, Kilts CD, Lewis MH. Thioridazine and the neuroleptic radioreceptor assay. Biological Psychiatry. 19: 833-47. PMID 6743721  0.68
1984 Niedzwiecki DM, Mailman RB, Cubeddu LX. Greater potency of mesoridazine and sulforidazine compared with the parent compound, thioridazine, on striatal dopamine autoreceptors. The Journal of Pharmacology and Experimental Therapeutics. 228: 636-9. PMID 6707914  0.68
1984 Walsh TJ, Tilson HA, DeHaven DL, Mailman RB, Fisher A, Hanin I. AF64A, a cholinergic neurotoxin, selectively depletes acetylcholine in hippocampus and cortex, and produces long-term passive avoidance and radial-arm maze deficits in the rat. Brain Research. 321: 91-102. PMID 6548653 DOI: 10.1016/0006-8993(84)90684-X  0.68
1984 Kilts CD, Knight DL, Mailman RB, Widerlöv E, Breese GR. Effects of thioridazine and its metabolites on dopaminergic function: drug metabolism as a determinant of the antidopaminergic actions of thioridazine. The Journal of Pharmacology and Experimental Therapeutics. 231: 334-42. PMID 6491985  0.68
1984 Lewis MH, Mobilio JN, Rissmiller DJ, Mailman RB. Thioridazine pharmacodynamics: clinical effects may depend upon drug metabolism. The Journal of the American Osteopathic Association. 84: 124-8. PMID 6490416  0.68
1984 Cooper CW, Twery MJ, Lewis MH, Mailman RB. Anorectic and other behavioral effects of centrally administered calcitonins. Psychopharmacology Bulletin. 20: 451-5. PMID 6473647  0.68
1984 Schulz DW, Wyrick SD, Mailman RB. [3H]SCH23390 has the characteristics of a dopamine receptor ligand in the rat central nervous system. European Journal of Pharmacology. 106: 211-2. PMID 6397360 DOI: 10.1016/0014-2999(84)90701-5  0.68
1984 DeHaven DL, Krigman MR, Gaynor JJ, Mailman RB. The effects of lead administration during development on lithium-induced polydipsia and dopaminergic function. Brain Research. 297: 297-304. PMID 6326940 DOI: 10.1016/0006-8993(84)90570-5  0.68
1984 Schulz DW, Mailman RB. An improved, automated adenylate cyclase assay utilizing preparative HPLC: effects of phosphodiesterase inhibitors. Journal of Neurochemistry. 42: 764-74. PMID 6319607  0.68
1984 Mailman RB, Schulz DW, Lewis MH, Staples L, Rollema H, Dehaven DL. SCH-23390: a selective D1 dopamine antagonist with potent D2 behavioral actions. European Journal of Pharmacology. 101: 159-60. PMID 6235121 DOI: 10.1016/0014-2999(84)90044-X  0.68
1984 DeHaven DL, Walsh TJ, Mailman RB. Effects of trimethyltin on dopaminergic and serotonergic function in the central nervous system. Toxicology and Applied Pharmacology. 75: 182-9. PMID 6206607 DOI: 10.1016/0041-008X(84)90200-X  0.68
1984 Hanin I, Krigman MR, Mailman RB. Central neurotransmitter effects of organotin compounds: trials, tribulations and observations. Neurotoxicology. 5: 267-77. PMID 6150454  0.68
1984 Mailman RB, DeHaven DL, Halpern EA, Lewis MH. Serum effects confound the neuroleptic radioreceptor assay. Life Sciences. 34: 1057-64. PMID 6142394 DOI: 10.1016/0024-3205(84)90019-5  0.68
1984 Schulz DW, Lewis MH, Petitto J, Mailman RB. Ascorbic acid decreases [3H]dopamine binding in striatum without inhibiting dopamine-sensitive adenylate cyclase Neurochemistry International. 6: 117-121. DOI: 10.1016/0197-0186(84)90035-4  0.68
1984 Mailman RB, Rollema H, Schulz DW. Dopamine receptor multiplicity: When the D1 antagonist is a D2 antagonist Federation Proceedings. 43: no. 4737.  0.68
1983 Twery MJ, Cooper CW, Mailman RB. Calcitonin depresses amphetamine-induced locomotor activity. Pharmacology, Biochemistry, and Behavior. 18: 857-62. PMID 6889413 DOI: 10.1016/S0091-3057(83)80005-7  0.68
1983 Mailman RB, Krigman MR, Frye GD, Hanin I. Effects of postnatal trimethyltin or triethyltin treatment on CNS catecholamine, GABA, and acetylcholine systems in the rat. Journal of Neurochemistry. 40: 1423-9. PMID 6834067  0.68
1983 Nemeroff CB, Luttinger D, Hernandez DE, Mailman RB, Mason GA, Davis SD, Widerlöv E, Frye GD, Kilts CA, Beaumont K, Breese GR, Prange AJ. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies. The Journal of Pharmacology and Experimental Therapeutics. 225: 337-45. PMID 6682440  0.68
1983 Mailman RB. Lithium-induced polydipsia: dependence on nigrostriatal dopamine pathway and relationship to changes in the renin-angiotensin system. Psychopharmacology. 80: 143-9. PMID 6410443 DOI: 10.1007/BF00427958  0.68
1983 Mailman RB, Lewis MH. Food additives and childhood hyperactivity. BoletíN De La AsociacióN MéDica De Puerto Rico. 75: 551-3. PMID 6320842  0.68
1983 Mailman RB, Lewis MH. Food additives and childhood hyperactivity. Asdc Journal of Dentistry For Children. 50: 283-6. PMID 6311882  0.68
1983 Lewis MH, Widerlöv E, Knight DL, Kilts CD, Mailman RB. N-oxides of phenothiazine antipsychotics: effects on in vivo and in vitro estimates of dopaminergic function. The Journal of Pharmacology and Experimental Therapeutics. 225: 539-45. PMID 6134814  0.68
1982 Widerlöv E, Häggström JE, Kilts CD, Andersson U, Breese GR, Mailman RB. Serum concentrations of thioridazine, its major metabolites and serum neuroleptic-like activities in schizophrenics with and without tardive dyskinesia. Acta Psychiatrica Scandinavica. 66: 294-305. PMID 7148482  0.68
1982 Mushak P, Krigman MR, Mailman RB. Comparative organotin toxicity in the developing rat: somatic and morphological changes and relationship to accumulation of total tin. Neurobehavioral Toxicology and Teratology. 4: 209-15. PMID 7088250  0.68
1982 Widerlöv E, Kilts CD, Mailman RB, Nemeroff CB, Mc Cown TJ, Prange AJ, Breese GR. Increase in dopamine metabolites in rat brain by neurotensin. The Journal of Pharmacology and Experimental Therapeutics. 223: 1-6. PMID 6811728  0.68
1982 Kilts CD, Patrick KS, Breese GR, Mailman RB. Simultaneous determination of thioridazine and its S-oxidized and N-demethylated metabolites using high-performance liquid-chromatography on radially compressed silica. Journal of Chromatography. 231: 377-91. PMID 6290516 DOI: 10.1016/S0378-4347(00)81862-9  0.68
1982 Sonstegard KS, Mailman RB, Cheek JM, Tomlin TE, DiAugustine RP. Morphological and cytochemical characterization of neuroepithelial bodies in fetal rabbit lung. I. Studies of isolated neuroepithelial bodies. Experimental Lung Research. 3: 349-77. PMID 6132813 DOI: 10.3109/01902148209069663  0.68
1981 Kilts CD, Breese GR, Mailman RB. Simultaneous quantification of dopamine, 5-hydroxytryptamine and four metabolically related compounds by means of reversed-phase high-performance liquid chromatography with electrochemical detection. Journal of Chromatography. 225: 347-57. PMID 7298770 DOI: 10.1016/S0378-4347(00)80283-2  0.68
1981 Abd-Elraof TK, Dauterman WC, Mailman RB. In vivo metabolism and excretion of propoxur and malathion in the rat: effect of lead treatment. Toxicology and Applied Pharmacology. 59: 324-30. PMID 7256771 DOI: 10.1016/0041-008X(81)90204-0  0.68
1981 Frye GD, Chapin RE, Vogel RA, Mailman RB, Kilts CD, Mueller RA, Breese GR. Effects of acute and chronic 1,3-butanediol treatment on central nervous system function: a comparison with ethanol. The Journal of Pharmacology and Experimental Therapeutics. 216: 306-14. PMID 7193248  0.68
1981 Vogel RA, Frye GD, Koepke KM, Mailman RB, Mueller RA, Breese GR. Differential effects of TRH, amphetamine, naloxone, and fenmetozole on ethanol actions: attenuation of the effects of punishment and impairment of aerial righting reflex. Alcoholism, Clinical and Experimental Research. 5: 386-92. PMID 6792942  0.68
1981 Kuhn CM, Vogel RA, Mailman RB, Mueller RA, Schanberg SM, Breese GR. Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats. Psychopharmacology. 73: 188-93. PMID 6785814 DOI: 10.1007/BF00429216  0.68
1981 Mailman RB, Lewis MH. Food additives and developmental disorders: the case of erythrosin (FD&C Red #3), or guilty until proven innocent? Applied Research in Mental Retardation. 2: 297-305. PMID 6174076 DOI: 10.1016/0270-3092(81)90025-4  0.68
1981 Mailman RB, Lewis MH, Kilts CD. Animal models related to developmental disorders: theoretical and pharmacological analyses. Applied Research in Mental Retardation. 2: 1-12. PMID 6171193 DOI: 10.1016/0270-3092(81)90002-3  0.68
1981 Breese GR, Mueller RA, Mailman RB, Frye GD. Effects of TRH on central nervous system function. Progress in Clinical and Biological Research. 68: 99-116. PMID 6117881  0.68
1981 Ondrusek MG, Kilts CD, Frye GD, Mailman RB, Mueller RA, Breese GR. Behavioral and biochemical studies of the scopolamine-induced reversal of neuroleptic activity. Psychopharmacology. 73: 17-22. PMID 6112768 DOI: 10.1007/BF00431093  0.68
1981 Mailman RB. . . And more comment [3] Chemical and Engineering News. 59: 3.  0.68
1981 Coyle S, Ondrusek MG, Mailman RB. Chronic treatment of neonatal rats with penfluridol results in permanent behavioral supersensitivity to apomorphine Federation Proceedings. 40: 7.  0.68
1981 Lewis MH, Mailman RB, Kilts CD. Anti-dopaminergic activity of N-oxides of several neuroleptics Federation Proceedings. 40: 8.  0.68
1981 Mailman RB, Kilts CD, Beaumont K, Breese GR. 'Supersensitivity' of dopamine systems: Comparisons between haloperidol withdrawal, intracisternal (IC) and unilateral (UNI) 6-hydroxydopamine (OHDA) treatments Federation Proceedings. 40: 323.  0.68
1981 Kilts CD, Mailman RB, Hodgson E, Breese GR. Simultaneous determination of thioridazine and its sulfoxidized metabolites by HPLC: Use in clinical and preclinical metabolic studies Federation Proceedings. 40: 11.  0.68
1980 Mailman RB, Ferris RM, Tang FL, Vogel RA, Kilts CD, Lipton MA, Smith DA, Mueller RA, Breese GR. Erythrosine (Red No. 3) and its nonspecific biochemical actions: what relation to behavioral changes? Science (New York, N.Y.). 207: 535-7. PMID 7352264  0.68
1980 Vogel RA, Frye GD, Wilson JH, Kuhn CM, Koepke KM, Mailman RB, Mueller RA, Breese GR. Attenuation of the effects of punishment by ethanol: comparisons with chlordiazepoxide. Psychopharmacology. 71: 123-9. PMID 6777811 DOI: 10.1007/BF00434399  0.68
1980 Pappas BA, Breese GR, Mailman RB, Mueller RA. Importance of the Locus coeruleus and involvement of alpha-adrenergic receptors in the post-decapitation reflex in the rat. Psychopharmacology. 69: 163-71. PMID 6256789 DOI: 10.1007/BF00427644  0.68
1980 Frye GD, Breese GR, Mailman RB, Vogel RA, Ondrusek MG, Mueller RA. An evaluation of the selectivity of fenmetozole (DH-524) reversal of ethanol-induced changes in central nervous system function. Psychopharmacology. 69: 149-55. PMID 6256788 DOI: 10.1007/BF00427641  0.68
1980 Frye GD, Vogel RA, Mailman RB, Ondrusek MG, Wilson JH, Mueller PA, Breese GR. A comparison of behavioral and neurochemical effects of ethanol and chlordiazepoxide. Advances in Experimental Medicine and Biology. 132: 729-37. PMID 6252770  0.68
1980 Mailman RB, Frye GD, Mueller RA, Breese GR. The effects of thyrotropin-releasing hormone (TRH) and other drugs on the actions of alcohol. Advances in Experimental Medicine and Biology. 126: 509-22. PMID 6250330  0.68
1980 Vogel RA, Frye GD, Wilson JH, Kuhn CM, Mailman RB, Mueller RA, Breese GR. Attenuation of the effect of punishment by thyrotropin-releasing hormone: comparisons with chlordiazepoxide. The Journal of Pharmacology and Experimental Therapeutics. 212: 153-61. PMID 6243358  0.68
1980 Mailman RB, Kilts CD, Mueller RA. Lithium (Li) administration does not reverse 6-hydroxydopamine (6-OHDA)-induced supersensitivity Federation Proceedings. 39: 3894.  0.68
1979 Breese GR, Lundberg DB, Mailman RB, Frye GD, Mueller RA. Effect of ethanol on cyclic nucleotides in vivo: consequences of controlling motor and respiratory changes. Drug and Alcohol Dependence. 4: 321-6. PMID 230951 DOI: 10.1016/0376-8716(79)90012-7  0.68
1979 Harden TK, Mailman RB, Mueller RA, Breese GR. Noradrenergic hyperinnervation reduces the density of beta-adrenergic receptors in rat cerebellum. Brain Research. 166: 194-8. PMID 217500 DOI: 10.1016/0006-8993(79)90664-4  0.68
1979 Lundberg DB, Breese GR, Mailman RB, Frye GD, Mueller RA. Depression of some drug-induced in vivo changes of cerebellar guanosine 3',5'-monophosphate by control of motor and respiratory responses. Molecular Pharmacology. 15: 246-56. PMID 38389  0.68
1979 Breese GR, Mueller RA, Mailman RB. Effect of dopaminergic agonists and antagonists on in vivo cyclic nucleotide content: relation of guanosine 3':5'- monophosphate (cGMP) changes in cerebellum to behavior. The Journal of Pharmacology and Experimental Therapeutics. 209: 262-70. PMID 35602  0.68
1979 Mailman RB, Frye GD, Mueller RA, Breese GR. Change in brain guanosine 3',5'-monophosphate (cGMP) content by thyrotropin-releasing hormone. The Journal of Pharmacology and Experimental Therapeutics. 208: 169-75. PMID 33261  0.68
1978 Mueller RA, Lundberg D, Frye GD, Mailman RB, Breese GR. Cerebellar cGMP varies with motor function and respiratory gas exchange. Neuroscience Letters. 10: 89-93. PMID 19605262 DOI: 10.1016/0304-3940(78)90017-4  0.68
1978 Nemeroff CB, Bissette G, Greeley GH, Mailman RB, Martin JB, Brazeau P, Kizer JS. Effects of acute administration of monosodium-L-glutamate (MSG), atropine or haloperidol on anterior pituitary hormone secretion in the rat. Brain Research. 156: 198-201. PMID 698833 DOI: 10.1016/0006-8993(78)90100-2  0.68
1978 Mailman RB, Krigman MR, Mueller RA, Mushak P, Breese GR. Lead exposure during infancy permanently increases lithium-induced polydipsia. Science (New York, N.Y.). 201: 637-9. PMID 675249  0.68
1978 Breese GR, Vogel RA, Kuhn CM, Mailman RB, Mueller RA, Schanberg SM. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine. Brain Research. 155: 263-75. PMID 308387 DOI: 10.1016/0022-4804(78)90153-1  0.68
1978 Mailman RB, Mueller RA, Breese GR. The effect of drugs which alter GABA-ergic function on cerebellar guanosine-3',5'-monophosphate content. Life Sciences. 23: 623-7. PMID 211362 DOI: 10.1016/0024-3205(78)90043-7  0.68
1978 Mailman RB, Frye GD, Mueller RA, Breese GR. Thyrotropin-releasing hormone reversal of ethanol-induced decreases in cerebellar cGMP. Nature. 272: 832-3. PMID 205800 DOI: 10.1038/272832a0  0.68
1973 Hodgson E, Philpot RM, Baker RC, Mailman RB. Effect of synergists on drug metabolism. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 1: 391-401. PMID 4149410  0.68
Show low-probability matches.